Curreio is a startup based in Japan, most recent round Series A, 1 tracked investor.
Curreio is a company headquartered in Japan. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Curreio is a biotechnology company focused on drug discovery using cryo-electron microscopy (Cryo-EM). The company specializes in high-resolution protein structure analysis to aid in the creation of new medications.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.